Abstract
Multifunctional nanomaterials have been extensively investigated in theranostics to enhance therapeutic specificity, biocompatibility, and responsiveness to external magnetic gradients. We synthesized magnetoplasmonic nanocomposites comprising magnetite nanoparticles modified with gold and silver. Magnetite was synthesized via chemical co-precipitation and stabilized in an aqueous medium using glucose, which also served as a reducing agent for Au(3+) and Ag(+) ions on the nanoparticle surface. Microstructural, magnetic, spectral, and optical characterizations confirmed the successful formation of nanocomposites with properties suitable for biomedical applications. Plasmonic behavior was evidenced by visible-range absorbance maxima at 398 nm (Ag) and 538 nm (Au), while Transmission Electron Microscopy (TEM) revealed mean diameters of 21 and 23 nm. Zeta potential values of +23 mV for magnetite-silver and -40 mV for magnetite-gold nanocomposite samples indicated good suspension stability. Antibacterial activity against Gram-positive and Gram-negative bacteria was evaluated using agar diffusion and by determining the minimum inhibitory (MIC) and bactericidal (MBC) concentrations. Silver-modified magnetite nanocomposites exhibited the most potent effects, with MIC values of 0.01 mg/mL for Escherichia coli (E. coli) and 0.02 mg/mL for Staphylococcus aureus (S. aureus), and corresponding MBC values of 0.027 mg/mL and 0.055 mg/mL, respectively. These magnetoplasmonic nanostructures have significant potential for overcoming antibiotic resistance and enabling targeted therapeutic action through magnetic guidance.